Search hospitals

>

Louisiana

>

Metairie

East Jefferson General Hospital

Claim this profile

Metairie, Louisiana 70006

Global Leader in Prostate Cancer

Global Leader in Lung Cancer

Conducts research for Kidney Cancer

Conducts research for Bladder Cancer

Conducts research for Renal Cell Carcinoma

93 reported clinical trials

11 medical researchers

Photo of East Jefferson General Hospital in MetairiePhoto of East Jefferson General Hospital in MetairiePhoto of East Jefferson General Hospital in Metairie

Summary

East Jefferson General Hospital is a medical facility located in Metairie, Louisiana. This center is recognized for care of Prostate Cancer, Lung Cancer, Kidney Cancer, Bladder Cancer, Renal Cell Carcinoma and other specialties. East Jefferson General Hospital is involved with conducting 93 clinical trials across 235 conditions. There are 11 research doctors associated with this hospital, such as Scott E. Delacroix, Brian C. Boulmay, Augusto C. Ochoa, and Agustin Garcia, M.D..

Area of expertise

1

Prostate Cancer

Global Leader

East Jefferson General Hospital has run 22 trials for Prostate Cancer. Some of their research focus areas include:

Stage IV
PD-L1 positive
hCG positive
2

Lung Cancer

Global Leader

East Jefferson General Hospital has run 20 trials for Lung Cancer. Some of their research focus areas include:

Stage III
Stage II
Stage I

Top PIs

Clinical Trials running at East Jefferson General Hospital

Prostate Cancer

Bladder Cancer

Ovarian Cancer

Kidney Cancer

Bladder Carcinoma

Uterine Cancer

Cancer

Pancreatic Cancer

Lung Cancer

Multiple Myeloma

Image of trial facility.

Standard Therapy + Surgery/Radiation

for Prostate Cancer

This phase III trial studies how well standard systemic therapy with or without definitive treatment (prostate removal surgery or radiation therapy) works in treating participants with prostate cancer that has spread to other places in the body. Addition of prostate removal surgery or radiation therapy to standard systemic therapy for prostate cancer may lower the chance of the cancer growing or spreading.

Recruiting

2 awards

Phase 3

30 criteria

Image of trial facility.

Apalutamide + Hormone and Radiation Therapies

for Prostate Cancer

This phase III trial studies whether adding apalutamide to the usual treatment improves outcome in patients with lymph node positive prostate cancer after surgery. Radiation therapy uses high energy x-ray to kill tumor cells and shrink tumors. Androgens, or male sex hormones, can cause the growth of prostate cancer cells. Drugs, such as apalutamide, may help stop or reduce the growth of prostate cancer cell growth by blocking the attachment of androgen to its receptors on cancer cells, a mechanism similar to stopping the entrance of a key into its lock. Adding apalutamide to the usual hormone therapy and radiation therapy after surgery may stabilize prostate cancer and prevent it from spreading and extend time without disease spreading compared to the usual approach.

Recruiting

2 awards

Phase 3

Image of trial facility.

Blood Sample Collection

for Cancer Detection

This study collects blood and tissue samples from patients with cancer and without cancer to evaluate tests for early cancer detection. Collecting and storing samples of blood and tissue from patients with and without cancer to study in the laboratory may help researchers develop tests for the early detection of cancers.

Recruiting

1 award

N/A

9 criteria

Similar Hospitals nearby

Frequently asked questions

What kind of research happens at East Jefferson General Hospital?